Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

SHE:002653 Revenue

Haisco Pharmaceutical Group had revenue of 1.56B CNY in the quarter ending March 31, 2026, with 75.33% growth. This brings the company's revenue in the last twelve months to 5.06B, up 31.04% year-over-year. In the year 2025, Haisco Pharmaceutical Group had annual revenue of 4.39B with 17.91% growth.

• Revenue (ttm): 5.06B
• Revenue Growth: +31.04%
• P/S Ratio: 12.01
• Revenue / Employee: 904.01K
• Employees: 5,597
• Market Cap: 60.74B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.39B	666.44M	17.91%
Dec 31, 2024	3.72B	366.28M	10.92%
Dec 31, 2023	3.36B	339.78M	11.27%
Jan 1, 2023	3.02B	241.98M	8.73%
Jan 1, 2022	2.77B	-556.28M	-16.71%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error